Administration, medication overview

Despite their favourable properties, peptide-based drugs are under-represented in the pharmaceutical market. This discrimination is usually due to their poor bioavailability, which sometimes necessitates non-oral administration or even special medical devices such as inhalers. Another related major disadvantage of peptides is their low metabolic stability due to proteolytic degradation, hi addition, costs of goods for the drug substance are sometimes tremendous. Therefore, there is considerable interest to transform the active principle of biologically active peptides into small molecules with improved pharmacokinetic properties, hi this chapter, we present an overview of... 

FDA, Food and Drug Administration (2013) Medical device classify your medical device. http //www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Overview/ClassifyYour Device/. Accessed 10 Aug 2013... 

Overview of Device Regulations, Medical Devices, U.S. Food and Drug Administration, available at www.fda.gov/MedicalDevices, accessed March 2012. 

---